Basic Biomedical and Translational HIV Science Discovery: Pilot Awards for Early-Stage Investigators
Supports early-stage California investigators conducting innovative pilot studies in basic and translational HIV biomedical research to advance prevention, treatment, or cure.
Funder: California HIV/AIDS Research Program
Due Dates: May 1, 2025 (Questions due, 5:00 PM) | May 14, 2026 (Required LOI, 12:00 Noon) | July 9, 2026 (Invited full application, 12:00 Noon)
Funding Amounts: Up to $200,000 in direct costs over two years per award; indirect costs capped at 40% MTDC.
Summary: Supports early-stage investigators in California conducting innovative basic and translational HIV research through mentored pilot studies.
Key Information: Only early-stage investigators at California non-profit institutions are eligible; a mentor and mentoring plan are required.
Description
This grant opportunity funds highly innovative pilot studies in basic and translational biomedical HIV research, specifically for early-stage investigators (ESIs) in California. The initiative aims to advance understanding of HIV prevention, treatment, or cure at the cellular or subcellular level, and to translate fundamental biomedical discoveries into interventions benefiting humans. Projects should generate preliminary data for larger grants, support the development of independent researchers through mentorship, and invest in the pipeline of future HIV investigators. Research must be HIV-specific, use rigorous and innovative approaches, and address basic biomedical or translational questions.
